Subscribe to RSS
DOI: 10.1055/a-1788-5600
Differences in Hemoglobin A1c during Pregnancy between Non-Hispanic Black versus White Women with Prepregnancy Diabetes
Funding K.K.V. was supported by the Care Innovation and Community Improvement Program at The Ohio State University.![](https://www.thieme-connect.de/media/ajp/202212/lookinside/thumbnails/10-1055-a-1788-5600_210859-1.jpg)
Abstract
Objective The objective of this was to determine whether the change in hemoglobin A1c (HbA1c) from early to late pregnancy differs between non-Hispanic Black and White women with prepregnancy diabetes.
Study Design A retrospective analysis was performed from an integrated prenatal and diabetes care program from 2012 to 2016. We compared HbA1c as a continuous measure and secondarily, HbA1c <6.5%, cross-sectionally, and longitudinally in early (approximately 10 weeks) and late (approximately 31 weeks) pregnancies. Linear and logistic regression were used and adjusted for age, body mass index, White diabetes class, medication use, diabetes type, gestational age at baseline HbA1c measurement, and baseline hemoglobin.
Results Among 296 non-Hispanic Black (35%) and White pregnant women (65%) with prepregnancy diabetes (39% type 1 and 61% type 2), Black women were more likely to experience increased community-level social determinants of health as measured by the Social Vulnerability Index (SVI) and were less likely to have type 1 diabetes and have more severe diabetes versus White women (p < 0.05). Black women had higher mean HbA1c (7.8 vs. 7.4%; beta: 0.75; 95% confidence interval [CI]: 0.30–1.19) and were less likely to have HbA1c < 6.5% at 10 weeks compared with White women (24 vs. 35%; adjusted odds ratio: 0.45; 95% CI: 0.24–0.81) but not after adjusting for SVI. At 31 weeks, both groups had similar mean HbA1c (both 6.5%) and were equally as likely to have HbA1c < 6.5% (57 vs. 54%). From early to late pregnancy, Black women had a higher percentage decrease in HbA1c (1.3 vs. 0.9%; beta = 0.63; 95% CI: 0.27–0.99) and were equally as likely to have an improvement or stable HbA1C < 6.5% from 10 to 31 weeks, with both groups having a similar mean HbA1c (6.5%) at 31 weeks.
Conclusion Despite experiencing greater community-level social determinants of health, Black women with pregestational diabetes had a larger reduction in HbA1c and were able to equally achieve the target of HbA1c < 6.5% by late pregnancy compared with White women as part of an integrated diabetes and prenatal care program.
Key Points
-
An integrated diabetes and pregnancy care program may decrease racial and ethnic disparities in glycemic control.
-
Black women had a larger reduction in HbA1c versus White women.
-
Black women were able to equally achieve the target of HbA1c < 6.5% by late pregnancy versus White women.
Authors' Contributions
K.K.V., N.F., J.J.J., and S.G.B. conceived of the study. Data collection and interpretation were conducted by M.K.K., C.A.W., E.B., M.C., M.B.L., and S.F.T. Data analysis was conducted by K.K.V., N.F., M.K.K., and J.J.J.
This manuscript will be presented as a poster presentation at the Society for Maternal-Fetal Medicine Annual Meeting, February, 2022.
Publication History
Received: 24 November 2021
Accepted: 22 February 2022
Accepted Manuscript online:
04 March 2022
Article published online:
25 May 2022
© 2022. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open 2016; 6 (01) e009494
- 2 Correa A, Bardenheier B, Elixhauser A, Geiss LS, Gregg E. Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993-2009. Matern Child Health J 2015; 19 (03) 635-642
- 3 Albrecht SS, Kuklina EV, Bansil P. et al. Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care 2010; 33 (04) 768-773
- 4 Bardenheier BH, Imperatore G, Devlin HM, Kim SY, Cho P, Geiss LS. Trends in pre-pregnancy diabetes among deliveries in 19 U.S. states, 2000-2010. Am J Prev Med 2015; 48 (02) 154-161
- 5 Zhang Q, Wang Y, Huang ES. Changes in racial/ethnic disparities in the prevalence of type 2 diabetes by obesity level among US adults. Ethn Health 2009; 14 (05) 439-457
- 6 Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010. Diabetes Care 2014; 37 (06) 1590-1596
- 7 Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 2009; 32 (11) 2005-2009
- 8 Gortazar L, Goday A, Flores-Le Roux JA. et al. Trends in prevalence of pre-existing diabetes and perinatal outcomes: a large, population-based study in Catalonia, Spain, 2006-2015. BMJ Open Diabetes Res Care 2020; 8 (01) e001254
- 9 Davidson AJF, Park AL, Berger H. et al. Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: a population-based cohort study. PLoS Med 2020; 17 (05) e1003104
- 10 Creanga AA, Bateman BT, Kuklina EV, Callaghan WM. Racial and ethnic disparities in severe maternal morbidity: a multistate analysis, 2008-2010. Am J Obstet Gynecol 2014; 210 (05) 435.e1-435.e8
- 11 Tennant PW, Glinianaia SV, Bilous RW, Rankin J, Bell R. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia 2014; 57 (02) 285-294
- 12 Starikov RS, Inman K, Chien EK. et al. Can hemoglobin A1c in early pregnancy predict adverse pregnancy outcomes in diabetic patients?. J Diabetes Complications 2014; 28 (02) 203-207
- 13 American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2020 . Diabetes Care 2020; 43 (Suppl. 01) S183-S192
- 14 Walker RJ, Strom Williams J, Egede LE. Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci 2016; 351 (04) 366-373
- 15 Jardine J, Walker K, Gurol-Urganci I. et al; National Maternity and Perinatal Audit Project Team. Adverse pregnancy outcomes attributable to socioeconomic and ethnic inequalities in England: a national cohort study. Lancet 2021; 398 (10314): 1905-1912
- 16 Hill-Briggs F, Adler NE, Berkowitz SA. et al. Social determinants of health and diabetes: a scientific review. Diabetes Care 2020; 44 (01) 258-279
- 17 Ogunwole SM, Golden SH. Social determinants of health and structural inequities-root causes of diabetes disparities. Diabetes Care 2021; 44 (01) 11-13
- 18 Golden SH, Joseph JJ, Hill-Briggs F. Casting a health equity lens on endocrinology and diabetes. J Clin Endocrinol Metab 2021; 106 (04) e1909-e1916
- 19 Smalls BLRT, Ritchwood TD, Bishu KG, Egede LE. Racial/ethnic differences in glycemic control in older adults with type 2 diabetes: United States 2003-2014. Int J Environ Res Public Health 2020; 17 (03) 950
- 20 Kahkoska AR, Shay CM, Crandell J. et al. Association of race and ethnicity with glycemic control and hemoglobin A1c levels in youth with type 1 diabetes. JAMA Netw Open 2018; 1 (05) e181851
- 21 Rodríguez JE, Campbell KM. Racial and ethnic disparities in prevalence and care of patients with type 2 diabetes. Clin Diabetes 2017; 35 (01) 66-70
- 22 Venkatesh KK, Joseph J, Kiefer M. et al. Association between Social Vulnerability and Achieving Glycemic Control among Pregnant Women with Pregestational Diabetes Obstertrics and Gynecology. In press.
- 23 Finneran MM, Kiefer MK, Ware CA. et al. The use of longitudinal hemoglobin A1c values to predict adverse obstetric and neonatal outcomes in pregnancies complicated by pregestational diabetes. Am J Obstet Gynecol MFM 2020; 2 (01) 100069
- 24 Finneran MM, Ware CA, Kiefer MK. et al. The accuracy and cost-effectiveness of selective fetal echocardiography for the diagnosis of congenital heart disease in patients with pregestational diabetes stratified by hemoglobin A1c. Am J Perinatol 2019; 36 (12) 1216-1222
- 25 Bio-Rad laboratories I. Variant II Turbo HbA1c Kit—2.0. U. S.. 2021 Accessed October 10, 2021, at: https://www.accessdata.fda.gov/cdrh_docs/reviews/K090699.pdf
- 26 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 201: pregestational diabetes mellitus. Obstert Gynecol 2018; 132 (06) e228-e48
- 27 Ingram DD, Parker JD, Schenker N. et al. United States Census 2000 population with bridged race categories. Vital Health Stat 2 2003; 2 (135) 1-55
- 28 Keppel K, Bilheimer L, Gurley L. Improving population health and reducing health care disparities. Health Aff (Millwood) 2007; 26 (05) 1281-1292
- 29 Institute of Medicine CoUaE-iRaEDiHCSB.. Stith AY, Nelson AR. eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academic Press; 2003
- 30 Centers for Disease Control and Prevention/ Agency for Toxic Substances and Disease Registry/ Geospatial Research A, and Services Program.. CDC/ATSDR Social Vulnerability Index 2021 Accessed October 10, 2021, at: https://www.atsdr.cdc.gov/placeandhealth/svi/data_documentation_download.html
- 31 Ahmad J, Rafat D. HbA1c and iron deficiency: a review. Diabetes Metab Syndr 2013; 7 (02) 118-122
- 32 Bennett SN, Tita A, Owen J, Biggio JR, Harper LM. Assessing White's classification of pregestational diabetes in a contemporary diabetic population. Obstet Gynecol 2015; 125 (05) 1217-1223
- 33 Kirk JK, Bell RA, Bertoni AG. et al. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother 2005; 39 (09) 1489-1501
- 34 Easter SR, Rosenthal EW, Morton-Eggleston E, Nour N, Tuomala R, Zera CA. Disparities in care for publicly insured women with pregestational diabetes. Obstet Gynecol 2017; 130 (05) 946-952
- 35 Palatnik A, Harrison RK, Walker RJ, Thakkar MY, Egede LE. Maternal racial and ethnic disparities in glycemic threshold for pharmacotherapy initiation for gestational diabetes. J Matern Fetal Neonatal Med 2022; 35 (01) 58-65
- 36 Shah VN, Snell-Bergeon JK, Demmitt JK. et al. Relationship between time-in-range, HbA1c, and the glucose management indicator in pregnancies complicated by type 1 diabetes. Diabetes Technol Ther 2021; 23 (12) 783-790
- 37 Singh P, Jonnalagadda P, Morgan E, Fareed N. Outpatient portal use in prenatal care: differential use by race, risk, and area social determinants of health. J Am Med Inform Assoc 2021; 29 (02) 364-371
- 38 Leziak K, Birch E, Jackson J, Strohbach A, Niznik C, Yee LM. Identifying mobile health technology experiences and preferences of low-income pregnant women with diabetes. J Diabetes Sci Technol 2021; 15 (05) 1018-1026
- 39 Kirk JK, D'Agostino Jr RB, Bell RA. et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006; 29 (09) 2130-2136
- 40 Gary TL, McGuire M, McCauley J, Brancati FL. Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization. Dis Manag 2004; 7 (01) 25-34
- 41 Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med 2007; 167 (17) 1853-1860
- 42 Shah NS, Wang MC, Freaney PM. et al. Trends in gestational diabetes at first live birth by race and ethnicity in the US, 2011-2019. JAMA 2021; 326 (07) 660-669
- 43 Kirk JK, Passmore LV, Bell RA. et al. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2008; 31 (02) 240-246
- 44 Toschi E, Michals A, Adam A. et al. Usefulness of CGM-derived metric, the glucose management indicator, to assess glycemic control in non-white individuals with diabetes. Diabetes Care 2021; 44 (12) 2787-2789